Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MDsleep
- Development stage
- Unknown
- Lead developer
- MDbio Wellness
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
MDsleep is a plant-based, multi-ingredient dietary supplement developed by MDbio Wellness to address sleeplessness and improve sleep quality. The formulation utilizes a synergistic blend of hemp-derived cannabinoids, including cannabidiol (CBD), cannabinol (CBN), and cannabigerol (CBG), alongside traditional botanical extracts such as valerian root and amino acids like gamma-aminobutyric acid (GABA) and L-theanine. MDbio partnered with Radicle Science to conduct large-scale, decentralized, blinded, placebo-controlled clinical trials to provide rigorous scientific validation for the product's efficacy in reducing sleep latency and enhancing overall sleep health. The product is designed to modulate the endocannabinoid system and inhibitory neurotransmitter pathways to promote relaxation without the side effects typically associated with synthetic sedatives.
- Brand names
- MDsleep
- Other names
- MDsleep Softgels
02
Targets
CNR1 (Cannabinoid receptor 1)GABA-B (Gamma-aminobutyric acid receptor type B)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on MDsleep.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MDsleep.